These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 26838725

  • 1. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X, Wang X, Thompson CD, Park S, Park WB, Lee JC.
    mBio; 2016 Feb 02; 7(1):e02232-15. PubMed ID: 26838725
    [Abstract] [Full Text] [Related]

  • 2. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A, Karaolis DK.
    Vaccine; 2009 Jul 30; 27(35):4867-73. PubMed ID: 19406185
    [Abstract] [Full Text] [Related]

  • 3. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
    Delfani S, Mohabati Mobarez A, Imani Fooladi AA, Amani J, Emaneini M.
    Med Microbiol Immunol; 2016 Feb 30; 205(1):47-55. PubMed ID: 26155981
    [Abstract] [Full Text] [Related]

  • 4. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C, Hamilton MM, Sadowska A, Shi Y, Chang CS, Chowdhury P, Buonapane R, Xiao X, Warrener P, Mediavilla J, Kreiswirth B, Suzich J, Stover CK, Sellman BR.
    mBio; 2016 Jun 28; 7(3):. PubMed ID: 27353753
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB.
    PLoS One; 2012 Jun 28; 7(9):e43813. PubMed ID: 22970144
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection.
    Anderson AS, Scully IL, Buurman ET, Eiden J, Jansen KU.
    mBio; 2016 Mar 08; 7(2):e00225. PubMed ID: 26956591
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.
    Misra N, Wines TF, Knopp CL, Hermann R, Bond L, Mitchell B, McGuire MA, Tinker JK.
    Vaccine; 2018 Jun 07; 36(24):3513-3521. PubMed ID: 29739718
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Begier E, Seiden DJ, Patton M, Zito E, Severs J, Cooper D, Eiden J, Gruber WC, Jansen KU, Anderson AS, Gurtman A.
    Vaccine; 2017 Feb 22; 35(8):1132-1139. PubMed ID: 28143674
    [Abstract] [Full Text] [Related]

  • 14. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
    Hawkins J, Kodali S, Matsuka YV, McNeil LK, Mininni T, Scully IL, Vernachio JH, Severina E, Girgenti D, Jansen KU, Anderson AS, Donald RG.
    Clin Vaccine Immunol; 2012 Oct 22; 19(10):1641-50. PubMed ID: 22896688
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
    Scully IL, Timofeyeva Y, Keeney D, Matsuka YV, Severina E, McNeil LK, Nanra J, Hu G, Liberator PA, Jansen KU, Anderson AS.
    Vaccine; 2015 Oct 05; 33(41):5452-5457. PubMed ID: 26319743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T.
    J Infect Dis; 2001 Dec 15; 184(12):1572-80. PubMed ID: 11740733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.